The integration of artificial intelligence (AI) into drug discovery is reshaping the pharmaceutical landscape. Generative chemistry, leveraging deep learning models, offers unprecedented capabilities ...

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup has ...

The traditional drug discovery process of identifying the causal mechanism of a disease, a single molecular target, and a drug against the target is slow, expensive, and fraught with the fallout ...

Developing new drugs to treat illnesses has typically been a slow and expensive process. However, a team of researchers at ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

Leading artificial intelligence (AI) driven drug discovery and bioinformatics, Dr. Sita Sirisha Madugula is making ...

A former scientist at Google's DeepMind who co-developed the AlphaFold2 protein prediction platform, Dr Simon Kohl, has launched his own venture applying artificial intelligence to drug discovery.

Scientists are using machine learning to find new treatments among thousands of old medicines. Scientists are using machine learning to find new treatments among thousands of old medicines.